All Infectious Disease articles – Page 14
-
NewsCOVID antiviral speeds recovery but doesn’t reduce hospitalization in vaccinated patients, trials find
Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials.
-
NewsHigh levels of gut bacterial toxin trigger lupus nephritis
Research suggests that using antibiotics to target the Ruminococcus gnavus lipoglycan, or the protein it activates on immune cell surfaces to amplify damaging inflammation, could serve as an alternative to current lupus nephritis therapies that suppress the immune system.
-
NewsScientists find a new way coronaviruses can get into human cells
An international team of researchers has identified an East African bat coronavirus capable of entering human cells. Whilst the virus can bind to a cell receptor found in the human lung, preliminary testing in Kenya suggests it has not spilled over into the local human population.
-
NewsScientists catch a fungal enzyme open for business
A new study shows that caspofungin, a widely used antifungal drug, works only when its target enzyme is active, pointing the way toward designing better treatments.
-
NewsResearch on tick-transmitted disease reveals potential weakness, opening paths to new treatments
Tularemia is a rare but highly infectious disease caused by Francisella tularensis, a bacterium that can evade immune defenses. Scientists have isolated and studied a set of proteins that play a central role in infection, revealing a potential weakness.
-
NewsNew clues to hepatitis B species restriction could help build a novel model for studying infection and testing therapies
For decades, it was thought that the barrier to creating a workable mouse model for hepatitis B is an inability for the virus to gain a genetic foothold in the mouse due to its unique type of DNA. Now researchers have discovered that the problem is something different altogether—likely a misstep in the entry process.
-
NewsWHO certifies the Bahamas for eliminating mother-to-child transmission of HIV
In a landmark achievement for Caribbean public health, the World Health Organization (WHO) congratulates The Bahamas for becoming the latest Caribbean nation to be certified as having eliminated the mother-to-child transmission of HIV.
-
CareersFrom one bench to another: Representing early-career scientists at Parliament’s Voice of the Future
Tyler Myers, an MPhil Candidate at the University of Cambridge, reports back from the Royal Society of Biology’s Voice of the Future event at Parliament, where he served as a guest panelist representing Applied Microbiology International.
-
NewsNasal spray could transform treatment of deadly cerebral malaria
Master’s student Taznita Kista is exploring whether a nano-enabled nasal spray could change how cerebral malaria is treated. Her work focuses on a nose-to-brain drug delivery system using niosomes.
-
NewsFlu vaccine no longer required for U.S. military
The U.S. military is ending its long-standing requirement that service members receive the annual flu shot, a decision announced by Defense Secretary Pete Hegseth.
-
NewsPioneering virologist Bernard Roizman dies at 96
Bernard Roizman, ScD, world-leading expert on herpes simplex virus (HSV) and Joseph Regenstein Distinguished Service Professor Emeritus of Microbiology and Molecular Genetics and Cell Biology at The University of Chicago, died on April 13, 2026, at the age of 96.
-
NewsResearchers disable antimicrobial resistance in cystic fibrosis-associated bacteria
A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance and a process known as cross-protection, the ability of resistant bacteria to shield nearby, otherwise sensitive strains.
-
NewsResearchers combine polarized light and a magnetic field to spot malaria under the microscope
Researchers have developed a new microscopy method that uses a magnetic field and polarized light to provide quantitative measurements that could enable faster and more objective detection of malaria in blood.
-
NewsRising measles cases highlight gaps in vaccination coverage and public health system vulnerabilities
The Global Virus Network (GVN) is closely monitoring a significant resurgence of measles in the United States and globally, reflecting a growing vulnerability in public health systems.
-
NewsCDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
-
NewsEarly immune responses linked to protective HIV antibodies
In a new study of broadly neutralizing antibodies and their potential for an HIV vaccine, researchers analyzed fragments of cell-free RNA and DNA circulating in the blood. This makes it possible to track immune responses, viral genetic variation, and other microbes from the same blood sample.
-
NewsNew research reveals cell proteins that drive severe viral infections
Researchers have identified two human cell proteins, NUP98 and NUP153, that play a crucial role in how viruses such as tick-borne encephalitis virus (TBEV), West Nile virus, and dengue virus replicate in the body.
-
NewsMillions suffering needlessly with curable hepatitis C, new analysis reveals
Millions of Americans are still battling potentially deadly hepatitis C even though they could be cured with antiviral drugs they are not receiving, a new analysis reveals.
-
NewsHas life-saving HIV therapy contributed to increased rates of a sexually transmitted disease?
A study has uncovered an unintended consequence of a major medical breakthrough: while the availability of HIV treatments in the late 1990s dramatically improved survival, they also contributed to a resurgence in syphilis, a sexually transmitted infection.
-
CareersQ&A: Meet Letters in Applied Microbiology Junior Editor Daniel Jesuwenu Ajose
We caught up with Daniel Jesuwenu Ajose, a Postdoctoral Research Fellow at the School of Biology and Environmental Sciences, University of Mpumalanga in South Africa, who is one of the newest Junior Editors with Letters in Applied Microbiology.